UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 401

Sortiert nach

Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox

Cancers, 2019-07, Vol.11 (8), p.1087

2019

Volltextzugriff (PDF)

Design of PCR assays to specifically detect and identify 37 Lactobacillus species in a single 96 well plate

BMC microbiology, 2020-04, Vol.20 (1), p.96-96, Article 96

2020

Volltextzugriff (PDF)

Platinum Monolayer Electrocatalyst on Gold Nanostructures on Silicon for Photoelectrochemical Hydrogen Evolution

ACS nano, 2013-07, Vol.7 (7), p.6017-6023

2013

Volltextzugriff (PDF)

PD-L1 in Breast Cancer: The Road to the Perfect Biomarker Is Fraught With Uncertainty

JNCI : Journal of the National Cancer Institute, 2021-08, Vol.113 (8), p.951-952

Lim, Bora

2021

Volltextzugriff (PDF)

Targeting Apoptosis in Cancer

Current oncology reports, 2022-03, Vol.24 (3), p.273-284

2022

Volltextzugriff (PDF)

Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system

The lancet oncology, 2017-04, Vol.18 (4), p.e228-e232

2017

Volltextzugriff (PDF)

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4780-4792

2017

Volltextzugriff (PDF)

Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites

Cancer biology & therapy, 2015-12, Vol.16 (12), p.1726-1737

2015

Volltextzugriff (PDF)

Update on systemic treatment for newly diagnosed inflammatory breast cancer

Journal of advanced research, 2021-03, Vol.29, p.1-12

2021

Volltextzugriff (PDF)

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy

PloS one, 2020-11, Vol.15 (11), p.e0241775

2020

Volltextzugriff (PDF)

Advancing Cancer Research and Medicine with Single-Cell Genomics

Cancer cell, 2020-04, Vol.37 (4), p.456-470

2020

Volltextzugriff (PDF)

Targeting Signaling Pathways in Inflammatory Breast Cancer

Cancers, 2020-09, Vol.12 (9), p.2479

2020

Volltextzugriff (PDF)

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

PloS one, 2021-04, Vol.16 (4), p.e0250057-e0250057

2021

Volltextzugriff (PDF)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype

PloS one, 2018-10, Vol.13 (10), p.e0204513-e0204513

2018

Volltextzugriff (PDF)

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Scientific reports, 2021-11, Vol.11 (1), p.22242-8, Article 22242

2021

Volltextzugriff (PDF)

Prognostic/predictive markers in systemic therapy resistance and metastasis in breast cancer

Therapeutic Advances in Medical Oncology, 2022, Vol.14, p.17588359221112698-17588359221112698

2022

Volltextzugriff (PDF)

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research

PloS one, 2020-04, Vol.15 (4), p.e0231953

2020

Volltextzugriff (PDF)

Identification of frequent somatic mutations in inflammatory breast cancer

Breast cancer research and treatment, 2017-06, Vol.163 (2), p.263-272

2017

Volltextzugriff (PDF)

Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications

American journal of clinical pathology, 2018-02, Vol.149 (3), p.253-261

2018

Volltextzugriff (PDF)

Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10

Cancer research (Chicago, Ill.), 2015-04, Vol.75 (8), p.1668-1674

2015

Volltextzugriff (PDF)

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer

Breast cancer research and treatment, 2014-06, Vol.145 (3), p.615-623

2014

Volltextzugriff (PDF)

Role of MR Imaging in Neoadjuvant Therapy Monitoring

Magnetic resonance imaging clinics of North America, 2018-05, Vol.26 (2), p.207-220

2018

Volltextzugriff (PDF)

MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer

Biochemical and biophysical research communications, 2017-08, Vol.489 (4), p.484-489

2017

Volltextzugriff (PDF)

A Randomized Controlled Trial of the Korean Version of the Program for the Education and Enrichment of Relational Skills for Young Adults (PEERS®-YA-K) With Autism Spectrum Disorder: A Pilot Study

Frontiers in psychiatry, 2021-10, Vol.12, p.730448-730448

2021

Volltextzugriff (PDF)

1 – 25 von 401

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(375)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox

Design of PCR assays to specifically detect and identify 37 Lactobacillus species in a single 96 well plate

Platinum Monolayer Electrocatalyst on Gold Nanostructures on Silicon for Photoelectrochemical Hydrogen Evolution

PD-L1 in Breast Cancer: The Road to the Perfect Biomarker Is Fraught With Uncertainty

Targeting Apoptosis in Cancer

Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer

Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites

Update on systemic treatment for newly diagnosed inflammatory breast cancer

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy

Advancing Cancer Research and Medicine with Single-Cell Genomics

Targeting Signaling Pathways in Inflammatory Breast Cancer

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Prognostic/predictive markers in systemic therapy resistance and metastasis in breast cancer

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research

Identification of frequent somatic mutations in inflammatory breast cancer

Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications

Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer

Role of MR Imaging in Neoadjuvant Therapy Monitoring

MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer

A Randomized Controlled Trial of the Korean Version of the Program for the Education and Enrichment of Relational Skills for Young Adults (PEERS®-YA-K) With Autism Spectrum Disorder: A Pilot Study

Suchergebnisse filtern